Skip to content

13F-HR filed by Weiss Multi-Strategy Advisers LLC

Weiss Multi-Strategy Advisers LLC filed this 13F-HR for the quarter ended 2018-06-30, filed 2018-08-14, with 533 holding rows worth $4,178,953,000.

Accession
0001062574-18-000008
Filed
2018-08-14
Accepted by EDGAR
acceptance time not in the bulk data set
Ingested
Source
SEC quarterly data set

Original filing

13F report for Q2 2018

A holdings report, 533 entries on the cover page, a total value of $4,178,953,000 stated on the cover page (in dollars after the unit check, H1), rows summing to $4,178,953,000 with VALUE read as thousands by filing date, 13F file number 028-12337. The quarter's positions are built on this report. The resolved quarter.

The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).

Issuer as filedCUSIPClassAmountValueValue read asType
Viewra, Inc92672L107COM54,823$379,000thousands by filing date
EPIZYME INC29428V104COM27,341$370,000thousands by filing date
TEGNA INC COM87901J105Stock32,200$349,000thousands by filing date
BUNGE LTDG16962105COM5,000$349,000thousands by filing dateput
EXTENDED STAY AMER INC30224P200UNIT 99/99/9999B15,988$346,000thousands by filing date
KARYOPHARM THERAPEUTICS INC48576U106COM20,000$340,000thousands by filing date
ALDEYRA THERAPEUTICS INC01438T106COM40,200$320,000thousands by filing date
BLUEPRINT MEDICINES CORP09627Y109COM5,000$317,000thousands by filing date
INSYS THERAPEUTICS INC45824V209COMMON STOCK43,830$317,000thousands by filing date
BIOHAVEN PHARMACEUTICAL HOLDING11196105COM8,000$316,000thousands by filing date
ObsEva SAH5861P103COM20,000$303,000thousands by filing date
ELECTRONIC ARTS INC COM285512109Stock2,000$282,000thousands by filing date
KERYX BIOPHARMACEUTICALS492515101COMMON STOCK67,929$255,000thousands by filing date
Inflarx NvN44821101COM7,600$245,000thousands by filing date
Accelerate Diagnostics00430H102COM11,001$245,000thousands by filing date
UNITED AIRLS HLDGS INC COM910047109Stock3,300$230,000thousands by filing date
AEGEAN MARINE PETROLEUM NETWY0017S102SHS347,000$230,000thousands by filing datecall
CYTOMX THERAPEUTICS INC23284F105COMMON STOCK10,000$229,000thousands by filing date
BARNES & NOBLE INC067774109COMMON STOCK35,000$222,000thousands by filing date
TRANSPORTATION & LOGISTI438083107COM10,000$204,000thousands by filing date
ACCENDRA HEALTH INC690732102COM10,993$184,000thousands by filing date
Ramaco Resources Inc75134P303COM CL B25,326$176,000thousands by filing date
PACIFIC BIOSCIENCES CALIF INC COM69404D108Stock49,326$175,000thousands by filing date
CYTOKINETICS INC23282W605COM NEW20,000$166,000thousands by filing date
AKEBIA THERAPEUTICS INC00972D105COMMON STOCK14,234$142,000thousands by filing date
IMMUNE DESIGN CORP.45252L103Common Stock27,500$125,000thousands by filing date
ARCUS BIOSCIENCES INC03969F109COM10,000$122,000thousands by filing date
ENDOLOGIX INC29266S106COM21,139$120,000thousands by filing date
CMB.TECH NV SHSB38564108Stock11,225$103,000thousands by filing date
AEGEAN MARINE PETROLEUM NETWY0017S102SHS152,675$101,000thousands by filing date
ALIMERA SCIENCES INC016259103COM84,122$82,000thousands by filing date
LADENBURG THALMANN FINANCIAL50575Q102COM19,259$65,000thousands by filing date
CURIS INC231269200COM26,519$46,000thousands by filing date

Amendment chain

FilingRoleFiledAcceptedIngested
13F-HR 0001062574-18-000008this filing2018-08-14acceptance time not in the bulk data set